BCL6 Is Required for the Maintenance of Leukemia-Initiating Cells In Chronic Myeloid Leukemia

被引：0
|
作者：
Hurtz, Christian [1 ]
Duy, Cihangir [1 ]
Cerchietti, Leandro [2 ]
Chatzi, Katerina [2 ]
Park, Eugene [3 ]
Klemm, Lars [1 ]
Kim, Yong-mi [3 ]
Kahn, Michael [4 ]
Braig, Melanie [5 ]
Muller, Martin C. [6 ]
Hochhaus, Andreas [7 ]
Ye, B. Hilda [8 ]
Melnick, Ari M. [9 ]
Muschen, Markus [1 ]
机构：
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Univ So Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA
[4] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA
[5] Lab Telomere & Stem Cell Biol, Hamburg, Germany
[6] Med Fak Mannheim, Mannheim, Germany
[7] Univ Klinikum Jena, Klin Innere Med 2, Jena, Germany
[8] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
[9] Weill Cornell Med Coll, Div Hematol Oncol, Dept Med, New York, NY USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：92 / 93
页数：2
相关论文
共 50 条
  • [21] Erratum: Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome
    J Chen
    Y Li
    M Doedens
    P Wang
    M Shago
    J E Dick
    J K Hitzler
    Leukemia, 2010, 24 : 1542 - 1542
  • [22] Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia
    Zhou, Jing
    Chen, Xing
    Zhou, Pan
    Sun, Xiaolu
    Chen, Yangpeng
    Li, Mengke
    Chu, Yajing
    Zhou, Jianfeng
    Hu, Xuelian
    Luo, Yi
    Yuan, Weiping
    Wang, Gaoxiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 600 : 29 - 34
  • [23] Maintenance of Leukemia-Initiating Cells Is Regulated by the CDK Inhibitor Inca1
    Baeumer, Nicole
    Baeumer, Sebastian
    Berkenfeld, Frank
    Stehling, Martin
    Koehler, Gabriele
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Tschanter, Petra
    PLOS ONE, 2014, 9 (12):
  • [24] Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Sato, Tomohiko
    Goyama, Susumu
    Kataoka, Keisuke
    Nasu, Ryo
    Tsuruta-Kishino, Takako
    Kagoya, Yuki
    Nukina, Arika
    Kumagai, Katsuyoshi
    Kubota, Naoto
    Nakagawa, Masahiro
    Arai, Shunya
    Yoshimi, Akihide
    Honda, Hiroaki
    Kadowaki, Takashi
    Kurokawa, Mineo
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    T Sato
    S Goyama
    K Kataoka
    R Nasu
    T Tsuruta-Kishino
    Y Kagoya
    A Nukina
    K Kumagai
    N Kubota
    M Nakagawa
    S Arai
    A Yoshimi
    H Honda
    T Kadowaki
    M Kurokawa
    Oncogene, 2014, 33 : 5028 - 5038
  • [26] A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia
    Zhang, Lin
    Wu, Min
    Guo, Weikai
    Zhu, Shuangshuang
    Li, Shen
    Lv, Shiyi
    Li, Yan
    Liu, Layang
    Xing, Yajing
    Chen, Huang
    Liu, Mingyao
    Peng, Shihong
    Chen, Yihua
    Yi, Zhengfang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [27] Leukemia-initiating Cells in T-Cell Acute Lymphoblastic Leukemia
    Tan, Shi Hao
    Bertulfo, Fatima Carla
    Sanda, Takaomi
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [28] Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia
    Krombholz, Christopher F.
    Gallego-Villar, Lorena
    Sahoo, Sushree S.
    Panda, Pritam K.
    Wlodarski, Marcin W.
    Aumann, Konrad
    Hartmann, Mark
    Lipka, Daniel B.
    Daskalakis, Michael
    Plass, Christoph
    Niemeyer, Charlotte M.
    Erlacher, Miriam
    Flotho, Christian
    LEUKEMIA, 2019, 33 (07) : 1805 - 1810
  • [29] Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia
    Christopher F. Krombholz
    Lorena Gallego-Villar
    Sushree S. Sahoo
    Pritam K. Panda
    Marcin W. Wlodarski
    Konrad Aumann
    Mark Hartmann
    Daniel B. Lipka
    Michael Daskalakis
    Christoph Plass
    Charlotte M. Niemeyer
    Miriam Erlacher
    Christian Flotho
    Leukemia, 2019, 33 : 1805 - 1810
  • [30] Modeling of C/EBPα mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
    Kirstetter, Peggy
    Schuster, Mikkel B.
    Bereshchenko, Oksana
    Moore, Susan
    Dvinge, Heidi
    Kurz, Elke
    Theilgaard-Monch, Kim
    Mansson, Robert
    Pedersen, Thomas A.
    Pabst, Thomas
    Schrock, Evelin
    Porse, Bo T.
    Jacobsen, Sten Eirik W.
    Bertone, Paul
    Tenen, Daniel G.
    Nerlov, Claus
    CANCER CELL, 2008, 13 (04) : 299 - 310
12345